Evidence map›Paper›PMID 35517346›Full record

ArticleRSC advances2020

Surface coating determines the inflammatory potential of magnetite nanoparticles in murine renal podocytes and mesangial cells.

Michal Selc, Filip Razga, Veronika Nemethova, Petra Mazancova, Monika Ursinyova, Marta Novotova, Kristina Kopecka, Alena Gabelova, Andrea Babelova

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Michal SelcDepartment of Nanobiology, Cancer Research Institute, Biomedical Research Center, Slovak Academy of Sciences Dubravska Cesta 9 84505 Bratislava Slovak Republic andrea.babelova@savba.sk +421-2-5477-4284 +421-2-322-95189.
Filip RazgaFaculty of Medicine, Comenius University Spitalska 24 81372 Bratislava Slovak Republic.
Veronika NemethovaFaculty of Medicine, Comenius University Spitalska 24 81372 Bratislava Slovak Republic.
Petra MazancovaFaculty of Medicine, Comenius University Spitalska 24 81372 Bratislava Slovak Republic.
Monika UrsinyovaSlovak Medical University Limbova 12 83303 Bratislava Slovak Republic.
Marta NovotovaInstitute of Experimental Endocrinology, Biomedical Research Center, Slovak Academy of Sciences Dubravska Cesta 9 84505 Bratislava Slovak Republic.
Kristina KopeckaDepartment of Nanobiology, Cancer Research Institute, Biomedical Research Center, Slovak Academy of Sciences Dubravska Cesta 9 84505 Bratislava Slovak Republic andrea.babelova@savba.sk +421-2-5477-4284 +421-2-322-95189.
Alena GabelovaDepartment of Nanobiology, Cancer Research Institute, Biomedical Research Center, Slovak Academy of Sciences Dubravska Cesta 9 84505 Bratislava Slovak Republic andrea.babelova@savba.sk +421-2-5477-4284 +421-2-322-95189.
Andrea BabelovaDepartment of Nanobiology, Cancer Research Institute, Biomedical Research Center, Slovak Academy of Sciences Dubravska Cesta 9 84505 Bratislava Slovak Republic andrea.babelova@savba.sk +421-2-5477-4284 +421-2-322-95189.ORCID https://orcid.org/0000-0001-9548-6602
Slovak Academy of Sciences · SKFaculty (United Kingdom) · GBSlovak Medical University · SK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Drug-induced nephrotoxicity is a frequent adverse event and a dose-limiting factor in patient treatment and is a leading cause of prospective drug attrition during pharmaceutical development. Despite the obvious benefits of nanotherapeutics in healthcare strategies, the clearance of imaging agents and nanocarriers from the body following their therapeutic or diagnostic application generates concerns about their safety for human health. Considering the potency of nanoparticles and their massive utilization in biomedicine the impact of magnetic nanoparticles (MNPs) on cells forming the filtration apparatus of the kidney was studied. Using primary mouse renal glomerular podocytes and mesangial cells, we investigated their response to exposure to magnetic nanoparticles coated with polyethylene glycol and bovine serum albumin. Cultured podocytes were more sensitive to MNPs than mesangial cells displaying signs of cell damage and stronger inflammatory response. Both types of MNPs induced the remodeling of actin fibers, affected the cell shape and triggered expression of inflammatory cytokines TNFα and IL-6 in podocytes. On the other hand, iNOS was induced in both renal cell types but only by MNPs with a polyethylene glycol coating. Our results have revealed that the type of cell and the type of nanoparticle coating might be the strongest determinants of cellular response toward nanoparticle exposure. Differences in susceptibility of cells to MNPs might be evident also between neighboring renal cell subpopulations integrally forming functional sub-units of this organ.

Identifiers

PMID35517346
PMCPMC9055089
OpenAlexW3036567450

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.